Disrupting LIN28 in atypical teratoid rhabdoid tumors reveals the importance of the mitogen activated protein kinase pathway as a therapeutic target
Rachael Maynard(Johns Hopkins University), Sariah J. Allen(St. Jude Children's Research Hospital), Anat Erdreich‐Epstein(University of Southern California), Jaclyn A. Biegel(University of Pennsylvania), Tracy Busse(Children's Hospital of Philadelphia), Brent A. Orr(St. Jude Children's Research Hospital), Antoinette Price(Johns Hopkins University), Eric H. Raabe(Johns Hopkins University), Jeffrey Rubens(Johns Hopkins University), Yasumichi Kuwahara(Kyoto Prefectural University of Medicine), Isabella Taylor(Johns Hopkins University), Marianne Hütt-Cabezas(NYU Langone Health), Melanie Weingart(Sidney Kimmel Comprehensive Cancer Center), Harpreet Kaur, Jingying Xu(Tongji University), Jacquelyn J. Roth(UPMC Hillman Cancer Center), Bernard E. Weissman(University of North Carolina at Chapel Hill), Xing gang Mao, Charles G. Eberhart(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711